CrushSCI.com
138.7Average days
142Median days
31Fastest days
226Longest days
1,6072025 publications

Paper Review Records

All Paper Review Records

16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

157 days

Dupilumab efficacy and safety in patients with allergic bronchopulmonary aspergillosis

Authors
Arnaud Bourdin; Jonathan Corren; Anand Shah; Caroline G. Baxter; Lavinia Davidescu; Heather Paleczny; Joseph A. Chiarappa; Andrew P. Fontenot; Paula Dakin; Elizabeth Laws; Jennifer Maloney; Lacey B. Robinson; George D. Yancopoulos; Allen RadinShow moreShow less
Affiliations
Department of Respiratory Diseases, PhyMedExp, University of Montpellier, INSERM CNRS, Montpellier, France; David Geffen School of Medicine at UCLA, Los Angeles, Calif; Respiratory Medicine, Royal Brompton Hospital, Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom; Department of Infectious Disease, School of Medicine, Centre of Bacterial Resistance Biology, Imperial College London, London, United Kingdom; Manchester University NHS Foundation Trust, Manchester, United Kingdom; Department of Pneumology, University of Oradea, Oradea, Romania; Regeneron Pharmaceuticals Inc, Tarrytown, NY; Sanofi, Cambridge, MassShow moreShow less
Source PDF DOI Publisher page
179 days

PRACTALL 2025: Artificial intelligence—application of allergy and immunology to patient care

Authors
Mohamed M. Shamji; Nicholas L. Rider; Ian Adcock; Thanai Pongdee; Stefano Del Giacco; Christopher Chang; Maria Jose Torres Jaén; Paul V. WilliamsShow moreShow less
Affiliations
National Heart and Lung Institute, Imperial College London, London, United Kingdom; NIHR Imperial Biomedical Research Centre, London, United Kingdom; Frankland and Kay Allergy Centre, Imperial College London, London, United Kingdom; Department of Health Systems and Implementation Science, Virginia Tech Carilion School of Medicine, Roanoke, Va; Section of Allergy and Immunology, Department of Pediatrics, The Carilion Clinic, Roanoke, Va; Division of Allergic Diseases, Mayo Clinic, Rochester, Minn; Department of Medical Sciences and Public Health, University of Cagliari, Monserrato, Italy; Division of Immunology, Allergy and Pediatric Rhematology, Memorial Healthcare System, Joe DiMaggio Children’s Hospital, Hollywood, Fla; Instituto de Investigación Biomédica de Málaga (IBIMA-Plataforma BIONAND), Málaga, Spain; Department of Environmental Health, University of Washington, Seattle, Wash; Department of Pediatrics, University of Washington, Seattle, WashShow moreShow less
Source PDF DOI Publisher page
89 days

Epitope-specific IgE profiles are predictive of desensitization and remission in the IMPACT trial

Authors
Julie Wang; Samane Khoshbakht; Kyung Won Lee; Stacie M. Jones; Michelle F. Huffaker; Marshall Plaut; Lisa M. Wheatley; Carolyn H. Baloh; Mayte Suárez-Fariñas; Hugh A. SampsonShow moreShow less
Affiliations
Division of Allergy and Immunology, Icahn School of Medicine at Mount Sinai, New York, NY; Center for Biostatistics, Department of Population Health Science & Policy, Icahn School of Medicine at Mount Sinai, New York, NY; Department of Pediatrics, Division of Allergy and Immunology, University of Arkansas for Medical Sciences and Arkansas Children’s Hospital, Little Rock, Ark; Immune Tolerance Network, Department of Medicine, Division of Pulmonary, Allergy, Critical Care Medicine, Stanford University, Stanford, Calif; The National Institute of Allergy and Infectious Disease, Bethesda, Md; Immune Tolerance Network, BRI at Virginia Mason, Seattle, Wash; Division of Allergy and Clinical Immunology, Brigham and Women’s Hospital, and Harvard Medical School, Boston, MassShow moreShow less
Source PDF DOI Publisher page
145 days

International perspective on obtaining disease modification with food allergy therapies

Authors
Aikaterini Anagnostou; Phillipe Bégin; Thomas Eiwegger; Matthew Greenhawt; Douglas P. Mack; Alkis TogiasShow moreShow less
Affiliations
Division of Allergy, Immunology & Retrovirology, Baylor College of Medicine, Houston, Tex; Division d’immunologie clinique, de rhumatologie et d’allergie, Département de pédiatrie, Centre hospitalier universitaire Sainte-Justine, Montreal, Quebec, Canada; Department of Pediatric and Adolescent Medicine, University Hospital St Pölten, St Pölten, Austria; Translational Medicine Program, SickKids Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada; Department of Immunology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Karl Landsteiner University of Health Sciences, Krems, Austria; Asthma and Allergy Foundation of America (AAFA), Arlington, Va; Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada; National Institute of Allergy and Infectious Diseases, Bethesda, MdShow moreShow less
Source PDF DOI Publisher page
153 days

Comparative efficacy of biologic agents for severe chronic rhinosinusitis with nasal polyps: Systematic review and network meta-analysis

Authors
Konstantinos Ouranos; Mark Michael; Evangelia K. Mylona; Sophia C. Mylonakis; Akash Guruswamy; Fadi Shehadeh; Tina Motazedi; David P. HustonShow moreShow less
Affiliations
Charles W. Duncan Jr Department of Medicine, Houston Methodist Hospital, Houston, Tex; School of Rural, Surveying and Geoinformatics Engineering, National Technical University of Athens, Athens, Greece; School of Electrical and Computer Engineering, National Technical University of Athens, Athens, Greece; Division of Allergy and Immunology, Immunology Center, Charles W. Duncan Jr. Department of Medicine, Houston Methodist Hospital, Houston, Tex; Naresh K. Vashisht College of Medicine, Texas A&M University, Houston, TexShow moreShow less
Source PDF DOI Publisher page
177 days

Dupilumab outcomes in pediatric asthma by early eosinophil status: Post hoc analysis of VOYAGE/EXCURSION

Authors
Sharon Dell; Theresa W. Guilbert; Antoine Deschildre; Wanda Phipatanakul; Nikolaos G. Papadopoulos; Clare S. Murray; Changming Xia; Andrew Moraco; Marissa Shams; Leonard B. BacharierShow moreShow less
Affiliations
Pediatric Respiratory Medicine, BC Children’s Hospital, Vancouver, British Columbia, Canada; University of British Columbia, Vancouver, British Columbia, Canada; Cincinnati Children’s Hospital and University of Cincinnati, Cincinnati, Ohio; CHU Lille, Université de Lille, and Pediatric Pulmonology and Allergy Department, Hôpital Jeanne de Flandre, Lille, France; Department of Allergy and Immunology, Boston Children’s Hospital, Boston, Mass; Department of Pediatrics, Harvard Medical School, Boston, Mass; National and Kapodistrian University of Athens, Athens, Greece; University of Manchester, Manchester, United Kingdom; Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom; Regeneron Pharmaceuticals Inc, Tarrytown, NY; Sanofi, Cambridge, Mass; Division of Allergy, Immunology and Pulmonary Medicine, Monroe Carell Jr. Children’s Hospital at Vanderbilt University Medical Center, Nashville, TennShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY take to review a manuscript?

As of 2026-11-19, CrushSCI has 16 complete review records for JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. The fastest paper went from submission to acceptance in 31 days (Practice parameter for inborn errors of immunity: What is new in the 2025 update, received 2026-04-14, accepted 2026-05-15); the slowest took 226 days. The average is 138.7 days and the median is 142 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.